
NYSEHealthcareMedical - Instruments & Supplies
Latest quote
$346.23
+$1.98 · +0.58%
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Previous close
$346.23
+$1.98 · +0.58%
After-hours
$346.23
$0.00 · 0.00%
Sep 11, 6:10 PM ET
Regular session · ET · Market data may be delayed.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Day range
Current $346.23
52-week range
Current $346.23
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
49
Fair Value
Sentiment
70
Bullish
Risk
23
Moderate Risk
Momentum
57
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Day range
Current $346.23
52-week range
Current $346.23
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.07B USD | 2.89B USD | 2.95B USD | 2.89B USD | 2.83B USD |
| Cost of goods sold | 1.97B USD | 1.89B USD | 1.82B USD | 1.75B USD | 1.66B USD |
| Gross profit | 1.1B USD | 1B USD | 1.13B USD | 1.14B USD | 1.17B USD |
| Research and development | 74.3M USD | 69.1M USD | 68.4M USD | 58.5M USD | 52.8M USD |
| Selling, general, and administrative | 393.1M USD | 338.5M USD | 353.4M USD | 316.9M USD | 361.9M USD |
| Operating expenses | 485.9M USD | 407.6M USD | 421.8M USD | 375.4M USD | 414.7M USD |
| Interest income | 17.7M USD | 19.6M USD | 28M USD | 5.1M USD | 1M USD |
| Interest expense | 600K USD | 2.9M USD | 8.8M USD | 7.6M USD | 8.5M USD |
| Depreciation and amortization | 124.4M USD | 155.4M USD | 137.3M USD | 120.6M USD | 122.3M USD |
| Operating income | 617.4M USD | 594.6M USD | 710.9M USD | 763.5M USD | 758.7M USD |
| Net income | 493.7M USD | 492.7M USD | 593.4M USD | 585.9M USD | 661.8M USD |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$407
17.55% upsideCash distributions grouped by calendar year; partial years are marked.
$0.85
2025 complete year+23.2% since 2021
2026 partial: $0.66
$0.69
2,021
$0.73
2,022
$0.77
2,023
$0.81
2,024
$0.85
2,025
$0.66
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jul 29, 2026 | $0.22Quarterly | Jul 29, 2026 | Aug 5, 2026 |
Dividend | Apr 29, 2026 | $0.22Quarterly | Apr 29, 2026 | May 6, 2026 |
Dividend | Jan 28, 2026 | $0.22Quarterly | Jan 28, 2026 | Feb 4, 2026 |
Dividend | Nov 12, 2025 | $0.22Quarterly | Nov 12, 2025 | Nov 19, 2025 |
Dividend | Jul 30, 2025 | $0.21Quarterly | Jul 30, 2025 | Aug 6, 2025 |
Dividend | Apr 30, 2025 | $0.21Quarterly | Apr 30, 2025 | May 7, 2025 |
Ex-dividend Jul 29, 2026
$0.22
Quarterly
Record Jul 29, 2026 · Payment Aug 5, 2026
Ex-dividend Apr 29, 2026
$0.22
Quarterly
Record Apr 29, 2026 · Payment May 6, 2026
Ex-dividend Jan 28, 2026
$0.22
Quarterly
Record Jan 28, 2026 · Payment Feb 4, 2026
Ex-dividend Nov 12, 2025
$0.22
Quarterly
Record Nov 12, 2025 · Payment Nov 19, 2025
Ex-dividend Jul 30, 2025
$0.21
Quarterly
Record Jul 30, 2025 · Payment Aug 6, 2025
Ex-dividend Apr 30, 2025
$0.21
Quarterly
Record Apr 30, 2025 · Payment May 7, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI767.03M0.03%2.3T USD0.03%$376.31+0.82%
Vanguard S&P 500 ETFVOO632.29M0.04%1.7T USD0.03%$702.56+0.85%
Vanguard Morningstar Mid-Cap ETFVO521.31M0.23%224.7B USD0.03%$81.03+0.78%
Vanguard Morningstar Growth ETFVUG318.48M0.09%372B USD0.03%$88.02+0.93%
iShares Core S&P 500 ETFIVV305.15M0.04%839.6B USD0.03%$767.92+0.84%
State Street SPDR S&P 500 ETFSPY298.9M0.04%799.37B USD0.09%$764.29+0.85%
Invesco S&P 500 Equal Weight ETFRSP198.21M0.20%97.99B USD0.20%$214.87+0.80%
Vanguard Morningstar Mid-Cap Growth ETFVOT184.2M0.55%33.5B USD0.05%$294.99+0.77%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Vanguard Morningstar Growth ETFVUG
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Invesco S&P 500 Equal Weight ETFRSP
Vanguard Morningstar Mid-Cap Growth ETFVOTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.